MED12 and leiomyoma: Using modified methods adapted for use with fresh tissue samples, we provide an extensive transcriptomic and epigenomic characterization of normal myometrium and MED12 mutant leiomyoma tissues, thereby yielding a near-faithful snapshot of the differences between myometrium and leiomyoma tissues under native conditions.